Skip to content

Clinical trials

Phase 3 Obesity trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Taiwan Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20091
20112
20141
20182
20191
20213
20224
20234
20242
20253
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting17
Active, not recruiting3
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company15
Novo Nordisk A/S11
Sanofi3
Amgen2
AstraZeneca2
Chang Gung Memorial Hospital2
Hoffmann-La Roche2
Taipei City Hospital2
Boehringer Ingelheim1
National Yang Ming Chiao Tung University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity42
Overweight24
Nutrition Disorders5
Diabetes Mellitus, Type 24
Sleep Apnea, Obstructive4
Dyslipidemias2
Heart Failure2
Hyperlipidemias2
Prediabetic State2
Atherosclerosis1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.